Seth Baum, MD, on PCSK9 Inhibitors: The Good, The Bad, and The Future

Dr Seth Baum, President of the American Society for Preventive Cardiology and cardiologist at Preventive Cardiology Inc in Boca Raton, FL, discusses his recent paper on PCSK9 inhibitors--their use, their FDA approval, and more.

For more content on cardiology topics, visit our Medical Resource Center.

Read Dr Baum's paper here.

Submit Feedback

Name